期刊文献+

综合治疗法在内分泌失调性骨质疏松症患者治疗中的应用价值 被引量:10

Application value of comprehensive therapy in patients with endocrine lost tonal osteoporosis
下载PDF
导出
摘要 目的探讨综合治疗法治疗内分泌失调性骨质疏松症患者的临床效果。方法选取我院2016年1月至2017年1月收治的100例内分泌失调性骨质疏松症患者为研究对象,随机分为两组,各50例。对照组采用常规药物治疗,观察组采用综合治疗法治疗。比较两组患者的治疗效果。结果观察组患者疼痛缓解总有效率显著高于对照组(P<0.05)。治疗后,两组患者的股骨颈、Wards三角区、大转子等部位的骨密度值均升高;观察组上述骨密度值均显著高于对照组(P<0.05)。结论采用性激素替代疗法、鲑鱼降钙素、促钙吸收剂等综合方式对内分泌失调性骨质疏松症患者实施治疗,效果显著,可推广应用。 Objective To investigate the clinical effect of comprehensive therapy patients with endocrine lost tonal osteoporosis. Methods A total of 100 patients with endocrine lost tonal osteoporosis admitted in our hospital from January2016 to January 2017 were selected and randomly divided into two groups, with 50 cases in each group. The control group took conventional drug treatment, the observation group took comprehensive therapy. The treatment effects of two groups were compared. Results The total effective rate of pain relief in the observation group was significantly higher than that in the control group(P〈0.05). After treatment, the bone mineral density of the femoral neck, Wards triangle area and greater trochanter in both groups increased, the above bone mineral density in the observation group were significantly higher than those in the control group(P〈0.05). Conclusion The sex hormone replacement therapy combined salmon calcitonin and calcium absorption absorbent are significantly effective in the treatment of endocrine lost tonal osteoporosis, and can be widely applied in clinic.
作者 张宏力
出处 《临床医学研究与实践》 2018年第3期34-35,共2页 Clinical Research and Practice
关键词 综合治疗法 内分泌失调性骨质疏松症 骨密度 comprehensive therapy endocrine lost tonal osteoporosis bone mineral density
  • 相关文献

参考文献9

二级参考文献50

  • 1章振林,何进卫,秦跃娟,黄琪仁,刘玉娟,胡云秋,李淼.骨代谢相关基因多态性与盐酸雷洛昔芬对绝经后骨质疏松妇女骨密度和骨转换指标影响的关系(英文)[J].中华医学遗传学杂志,2006,23(2):129-133. 被引量:5
  • 2林伯庚,陈治卿,陈鹭玲.降钙素对骨质疏松症治疗的临床观察[J].中国骨质疏松杂志,2006,12(5):490-491. 被引量:17
  • 3Rosen CJ. Clinical practice. Vitamin D insufficiency [J]. N Engl J Med, 2011,36 (4) : 248 -254. 被引量:1
  • 4Lambert JK, Zaidi M, Mechanick JI. Male osteoporosis: epidemiology and the pathogenesis of aging bones [J]. Curr Osteoporos Rep, 2011,21 (9) : 229-236. 被引量:1
  • 5Rossini, M. Acute phase response after zoledronic acid is associated with long-term effects on white blood cells. Calcif Tissue International, 2013, 93 ( 3 ) :249-252. 被引量:1
  • 6Silverman SL, Kriegman A, Goncalves J, et al. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid. Osteoporosis International, 2011, 22 (8) : 2337-2345. 被引量:1
  • 7Wark J, Recknor C, Ryabitseva O, et al. Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg. Osteoporosis International, 2012,23 ( 2 ) : 503-512. 被引量:1
  • 8Lewiecki EM. Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect. Core Evid, 2009, 4(1) :13-23. 被引量:1
  • 9Dicuonzo G, Vincenzi B, Santini D, et al. Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res, 2003,23 (11 ) : 649-654. 被引量:1
  • 10Reid I R. Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab, 2010, 95(9). 4380-4387. 被引量:1

共引文献199

同被引文献47

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部